CRIS - Curis, Inc. Stock Analysis | Stock Taper

SCREENER COMPARE ANY 2 STOCKS

CRIS

CURIS, INC.

NASDAQ

$1.35

▼ DOWN 1.46% (-0.02)

KEY STATISTICS

Market Cap$2.61 M

52w High$39.00

52w Low$1.30

Dividend Yield—

Frequency—

P/E-0.86

Volume96.90K

Shares Out.1.95M

COMPANY

LEADERSHIP

James E. Dentzer

CHIEF EXECUTIVE

James E. Dentzer

COMPENSATION 2026

Salary$633,500

Stock Awards$0

Incentive Plan Pay$418,110

All Other Comp.$22,368

Total$1,662,978

ABOUT

SECTOR

Healthcare

WENT PUBLIC

August 1, 2000

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

22

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$1.00M

NOV

5

THU

SPLIT RECORD

DATE	TYPE	RATIO
2026-07-06	Reverse	1:20
2023-09-29	Reverse	1:20
2018-05-30	Reverse	1:5

PRICE

$1.35 ▼ DOWN 1.46% (−$0.02)

OVERLAYS

About Curis, Inc.

https://www.curis.com ↗

Curis, Inc. is a Massachusetts-based biotech developing cancer therapies, including clinical-stage drugs like Emavusertib and Fimepinostat, with collaborations with Roche and Aurigene.

INDUSTRY

Biotechnology

A PRODUCT CURIS, INC. IS KNOWN FOR

Emavusertib (CA-4948)

Emavusertib (CA-4948)

Emavusertib is an oral IRAK4 and FLT3 inhibitor in clinical trials for hematologic malignancies like PCNSL, AML, and MDS, and is Curis's lead drug candidate.

COMPETITORS

COMPETITOR

Revenue by Products

Icon	PRODUCT	Q1-2025	Q2-2025	Q3-2025	Q4-2025
	Reportable Segment	$2.38M	$2.75M ▲	$3.18M ▲	$1.14M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING

11

LISTED HERE

1

RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED

100.00%

HOLDERS

66

TOP 12 OF 66 · RANKED BY POSITION SIZE

Bleichroeder LP

3.8M sh · $2.08M

Stonepine Capital Management, LLC

3.7M sh · $2.04M

Nantahala Capital Management, LLC

2.0M sh · $1.09M

Sphera Funds Management Ltd.

2.0M sh · $1.09M

Cable Car Capital LLC

1.3M sh · $729.73K

Armistice Capital, LLC

978.2K sh · $1.62M

Dauntless Investment Group, LLC

658.7K sh · $362.3K

581.1K sh · $964.66K

M28 Capital Management LP

521.1K sh · $514.34K

Vanguard Group Inc

367.6K sh · $610.25K

Renaissance Technologies LLC

366.7K sh · $200.72K

Cm Management, LLC

325.0K sh · $320.81K

RATINGS SNAPSHOT

Overall rating: C-

Discounted Cash Flow1

Return On Equity1

Return On Assets1

Debt To Equity3

Price To Earnings1

Price To Book2

Overall Score1

INSIDER TRADES

★

DIRECTOR

Hohneker John

Purchase · 6.8K shares

2026-07-07

★

DIRECTOR, OFFICER: PRESIDENT & CEO

Dentzer James E

Purchase · 110.1K shares

2026-07-07

★

DIRECTOR

KAITIN KENNETH I

Purchase · 6.8K shares

2026-07-07

★

DIRECTOR

Borgman Anne Elizabeth

Purchase · 6.8K shares

2026-07-07

MOST RECENT ANALYST GRADES

GRADE SUMMARY

BUY 1

1 GRADES IN THE LAST 12 MONTHS

HC Wainwright & Co. BUY

SECTORS PEERS

PEER	PRICE
PALI	$2.08	COMPARE
BCTX	$3.53	COMPARE
ICU	$2.96	COMPARE
CTXR	$0.59	COMPARE
PCSA	$2.02	COMPARE
ASBP	$9.09	COMPARE